GSK-3 Inhibitors: Anti-Diabetic Treatment Associated With Cardiac Risk?
Cardiovascular Drugs and Therapy - Netherlands
doi 10.1007/s10557-016-6669-y
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2016
Authors
Publisher
Springer Science and Business Media LLC